Cholinergic syndrome is a predictable cluster of symptoms that occurs when the neurotransmitter acetylcholine builds up to excessive levels in the body, overstimulating the nerves that control everything from heart rate and breathing to digestion and muscle movement. The most common triggers are organophosphate pesticides, certain medications, nerve agents, and natural toxins like those found in some wild mushrooms. Because the syndrome can progress to respiratory failure within hours, recognizing its characteristic pattern of profuse sweating, excessive salivation, small pupils, muscle twitching, and diarrhea is one of the most time-sensitive skills in emergency medicine.
Why Acetylcholine Builds Up
Under normal conditions, acetylcholine is released at nerve endings to transmit a signal, then almost immediately broken down by an enzyme called acetylcholinesterase. That rapid cleanup keeps nerve firing crisp and brief. Cholinergic syndrome develops when something blocks or overwhelms that cleanup process, allowing acetylcholine to accumulate and continuously stimulate receptors throughout the nervous system.1PubMed Central. Acetylcholinesterase inhibitors: pharmacology and toxicology The result is a kind of system-wide overload: glands pour out secretions, smooth muscles contract, skeletal muscles twitch uncontrollably, and the brain can become overwhelmed to the point of seizures or coma.
This excess acetylcholine acts on two broad categories of receptors. Muscarinic receptors are found in smooth muscle, glands, and the heart; their overstimulation accounts for the “wet” symptoms like drooling, tearing, urination, and diarrhea. Nicotinic receptors sit at the junctions between nerves and skeletal muscles and within parts of the autonomic nervous system; their overstimulation produces muscle twitching, weakness, and sometimes a rapid heart rate that can mask the slow heart rate driven by muscarinic effects. This distinction matters for treatment because atropine blocks muscarinic receptors but does nothing for nicotinic effects.2PubMed Central. Clinical features of organophosphate poisoning: A review of different classification systems and approaches
Organophosphate Pesticides and Nerve Agents
The most frequent cause of cholinergic syndrome worldwide is poisoning by organophosphate pesticides, which are widely used in agriculture. These compounds work by forming a chemical bond with the active site of acetylcholinesterase, effectively locking the enzyme in an “off” position so it can no longer break down acetylcholine.3PubMed Central. Acetylcholinesterase: Structure, dynamics, and interactions with organophosphorus compounds Exposure can happen through skin absorption, inhalation of sprayed droplets, or accidental ingestion.
Nerve agents like sarin, soman, tabun, and VX exploit the same mechanism but are engineered to be far more potent. They phosphonylate the enzyme’s active-site serine and then undergo a secondary reaction called “aging,” which makes the bond essentially permanent and prevents any antidote from reactivating the enzyme.4PubMed. Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level The speed of this aging varies by agent: soman ages within minutes, while other agents give a somewhat longer window for treatment. The first organophosphorus nerve agent was actually discovered by accident during pesticide research in the years following World War I, and the line between agricultural chemicals and weapons-grade compounds has been uncomfortably thin ever since.5PubMed. The risk associated with organophosphorus nerve agents: from their discovery to their unavoidable threat, current medical countermeasures and perspectives
Medications That Can Trigger It
Cholinergic syndrome does not only come from toxic exposures. Medications called cholinesterase inhibitors, prescribed to improve cognitive function in Alzheimer’s disease, work by the same basic mechanism: they slow the breakdown of acetylcholine. Donepezil is the most commonly prescribed of these. At normal doses it is well tolerated, but an overdose can produce the full cholinergic picture, from gastrointestinal distress to serious cardiac rhythm disturbances.6PubMed. Cholinergic symptoms and QTc prolongation following donepezil overdose Rivastigmine, another drug in the same class, has been implicated in pediatric poisonings when young children accidentally ingest a grandparent’s medication. One reported case involved a three-year-old girl who developed the full syndrome, including altered mental status, respiratory failure, and transient cardiac rhythm abnormalities, after swallowing just one or two pills.7PubMed. Transient cardiac effects in a child with acute cholinergic syndrome due to rivastigmine poisoning
Other medications that can tip the balance include certain drugs used to reverse neuromuscular blockade after surgery (like neostigmine) and some eye drops used for glaucoma. In most of these cases, cholinergic symptoms are a known risk rather than a surprise, and they resolve once the drug is reduced or stopped.
Mushrooms and Other Natural Toxins
Wild mushroom poisoning is an underappreciated source of cholinergic symptoms. Certain species in the genera Clitocybe, Inosperma, and Pseudosperma contain the alkaloid muscarine, which directly activates muscarinic receptors rather than blocking acetylcholinesterase. The effect is the same sweating, salivation, tearing, and diarrhea seen in organophosphate poisoning, but the onset tends to be rapid, usually within 30 minutes to two hours of eating the mushrooms.8PubMed Central. Muscarinic toxicity among family members after consumption of mushrooms9Food Control. Foodborne illness caused by muscarine-containing mushrooms and identification of mushroom remnants using phylogenetics and LC-MS/MS Because the mechanism is direct receptor stimulation rather than enzyme inhibition, these patients respond well to atropine and supportive care. The absence of nicotinic symptoms (muscle twitching, fasciculations) can be a useful clinical clue to distinguish mushroom-related muscarinic toxicity from organophosphate poisoning.
Recognizing the Symptoms
Emergency physicians use the mnemonic SLUDGE to remember the hallmark muscarinic symptoms: Salivation, Lacrimation (tearing), Urination, Defecation (diarrhea), Gastrointestinal distress, and Emesis (vomiting). Some versions add “BBB” for Bradycardia (slow heart rate), Bronchorrhea (fluid flooding the airways), and Bronchospasm (airway constriction). Recognizing this cluster as a toxidrome, a distinct poisoning pattern, allows rapid identification even before lab results come back.10BMJ Journals. Toxidromes and a general approach to poisoning
Nicotinic symptoms layer on top of this in more severe poisonings. These include muscle fasciculations (visible rippling under the skin), weakness, and sometimes paralysis. The pupils are characteristically pinpoint. Central nervous system effects range from anxiety and restlessness early on to confusion, seizures, and coma in severe cases. One confusing wrinkle is that nicotinic stimulation of the adrenal glands can release adrenaline, causing a fast heart rate and high blood pressure that temporarily mask the muscarinic slow heart rate. This can mislead clinicians who expect every cholinergic patient to have a slow pulse.
How Doctors Confirm the Diagnosis
The clinical picture is usually distinctive enough to begin treatment immediately, but blood tests for cholinesterase activity help confirm the diagnosis and gauge severity. Two enzymes are measured: plasma butyrylcholinesterase and red blood cell acetylcholinesterase. Plasma butyrylcholinesterase drops first and is more sensitive to inhibitors, making it a useful marker of exposure. Red blood cell acetylcholinesterase is the same enzyme that matters at nerve synapses, so its level better reflects how badly nerve function is actually impaired.11Clinical Chemistry. Cholinesterase inhibition: complexities in interpretation
Neither test is perfect on its own. The two enzyme levels do not always track together: a person can show a clinically significant drop in one marker but not the other. Monitoring programs for agricultural workers exposed to pesticides now measure both, because relying on just one can miss real cases of cholinesterase depression.12Occupational and Environmental Medicine. Blood acetylcholinesterase and butyrylcholinesterase as biomarkers of cholinesterase depression among pesticide handlers Red blood cell acetylcholinesterase also has wide natural variation between individuals, so comparing a person’s current level to their own baseline (taken before any exposure) is far more useful than comparing it to population averages.
Treatment in the Acute Phase
The cornerstone of treatment is atropine, which blocks muscarinic receptors and dries up the dangerous bronchial secretions that can drown the airways. Doses far larger than those used for other medical purposes are sometimes required. How the atropine is dosed matters: a study comparing a structured doubling-dose approach against ad hoc high-dose regimens found that the titrated approach used less atropine overall and produced dramatically fewer complications like delirium and hallucinations, without worsening patient outcomes.13PubMed Central. Comparison of two commonly practiced atropinization regimens in acute organophosphorus and carbamate poisoning, doubling doses vs. ad hoc: a prospective observational study The target is to dry airway secretions and bring the heart rate into a safe range, not to achieve a specific total dose.
Oximes, most commonly pralidoxime, are the second pillar of treatment. They work by prying the organophosphate off the enzyme and reactivating acetylcholinesterase before aging locks the bond permanently. Their effectiveness depends heavily on which organophosphate was involved. Diethyl compounds (like parathion and chlorpyrifos) age slowly, giving oximes a wider window to work, sometimes days after exposure.14PubMed. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning Dimethyl compounds age much faster, which can make oxime therapy less effective, especially in cases of massive ingestion.15PubMed. The role of oximes in the management of organophosphorus pesticide poisoning For patients poisoned by a diethyl compound, continuing oxime infusions even when initial improvement is not obvious can still pay off once the poison load drops.
Seizures are a serious complication that requires prompt treatment, particularly after nerve agent exposure. Benzodiazepines, especially midazolam, are the drugs of choice. Midazolam enhances the brain’s inhibitory signaling and has been shown to control seizures triggered by multiple different nerve agents in animal studies.16Toxicology and Applied Pharmacology. Control of nerve agent-induced seizures is critical for neuroprotection and survival17PubMed Central. Midazolam as an anticonvulsant antidote for organophosphate intoxication–A pharmacotherapeutic appraisal Speed matters because prolonged seizure activity causes its own wave of brain damage independent of the original poisoning.
Decontamination and Protecting Rescuers
Organophosphates can continue to absorb through the skin or evaporate from clothing and vomit, posing a real risk to healthcare workers and bystanders. A case analysis of secondary contamination in a hospital setting found that problems included delayed recognition that decontamination was needed, too many staff coming into unnecessary contact with the patient, and the difficulty of performing medical procedures while wearing protective equipment.18QJM: An International Journal of Medicine. Secondary contamination in organophosphate poisoning: analysis of an incident Even a patient who swallowed the poison can create a chemical hazard if they vomit.
The practical lesson is that decontamination, meaning removing clothing and thoroughly washing the skin, should happen as early as possible and before the patient enters treatment areas. Rapid identification of the specific pesticide on the skin can guide how aggressive decontamination needs to be and confirm when it has been adequate.19PubMed. Rapid identification of organophosphorus pesticides on contaminated skin and confirmation of adequate decontamination by ambient mass spectrometry in emergency settings For nerve agent exposures, military and civilian protocols call for specific chemical decontamination kits and a defined perimeter to protect responders.
Intermediate Syndrome
Surviving the initial cholinergic crisis does not mean the danger is over. A subset of organophosphate-poisoned patients develop what is called the intermediate syndrome, typically becoming apparent two to four days after exposure, just as the acute muscarinic signs like drooling and fasciculations are fading.20PubMed. Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy The hallmark is progressive weakness of the respiratory muscles (diaphragm, the muscles between the ribs, and neck muscles) along with weakness in the upper arms and thighs. Patients may be alert and able to move their limbs weakly but completely unable to breathe on their own, pointing to a failure at the nerve-muscle junction rather than in the brain.
A prospective study from Sri Lanka found that some patients showed early electrophysiological signs of the syndrome within the first 24 hours, well before the classic clinical window, and that the onset of muscle weakness ranged from 15 hours to 6 days.21PLoS Medicine. The Spectrum of Intermediate Syndrome Following Acute Organophosphate Poisoning: A Prospective Cohort Study from Sri Lanka Roughly a third of patients in another series required intubation for the first time more than 24 hours after admission, with a median time to respiratory failure around 64 hours.22PubMed Central. Respiratory Failure in Acute Organophosphorus Pesticide Self-Poisoning There is no specific antidote for intermediate syndrome; the treatment is mechanical ventilation and time. Most patients recover over one to three weeks as new acetylcholinesterase is synthesized.
Delayed Neuropathy
A third phase, quite separate from the intermediate syndrome, can appear one to three weeks after exposure to certain organophosphates. Called organophosphorus compound-induced delayed neurotoxicity (OPIDN), it involves degeneration of long nerve fibers in both the central and peripheral nervous system.23PubMed Central. Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN) The molecular target is not acetylcholinesterase but a different enzyme called neuropathy target esterase (NTE). When certain organophosphates inhibit more than about 70 percent of NTE and the resulting bond undergoes aging, a wave of axonal damage follows roughly two weeks later.24PubMed. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy
Clinically, this looks like a peripheral neuropathy starting in the feet and legs: numbness, tingling, then weakness progressing upward. Some patients also develop spastic weakness in the legs due to damage in the spinal cord. Not all organophosphates cause this; the compounds that do tend to be the ones that interact strongly with NTE. Importantly, NTE inhibition in easily sampled cells like lymphocytes can predict whether neuropathy will develop, offering a potential early warning tool.25PubMed. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy Recovery from OPIDN is often incomplete, especially if the central nervous system is involved.
Long-Term Cognitive and Psychological Effects
Even people who appear to recover fully from acute organophosphate poisoning can carry lasting neurological effects. A study comparing survivors of severe poisoning with matched controls found clear differences on neuropsychological testing, including worse performance on measures of intellectual functioning, abstract thinking, flexibility of thought, and simple motor skills. Twice as many poisoned individuals as controls scored in the range associated with brain damage or dysfunction on a standard neuropsychological battery. Personality testing also revealed more emotional distress and self-reported disability among the poisoned group.26PubMed. Chronic neurological sequelae of acute organophosphate pesticide poisoning
These findings align with a broader pattern seen in occupational health research: chronic low-level pesticide exposure and single severe poisoning episodes can both leave cognitive footprints that persist for years. Memory problems, difficulty concentrating, mood changes, and reduced processing speed are the most consistently reported complaints. The mechanisms likely involve direct neurotoxic damage during the acute event, prolonged seizure-related injury, and possibly hypoxic damage from respiratory compromise before treatment began.
When Cholinergic Symptoms Come from Unexpected Sources
Most discussions of cholinergic syndrome focus on pesticides or nerve agents, but clinicians occasionally encounter the syndrome from sources that catch everyone off guard. Household insecticides, flea collars containing organophosphates, and contaminated food have all been implicated. In children, accidental ingestion of a grandparent’s Alzheimer’s medication is a recurring scenario, and it can produce the full syndrome from just one or two pills. The cardiac effects in children deserve special attention: the rivastigmine poisoning case mentioned earlier produced ventricular rhythm disturbances that resolved over time but required intensive monitoring.7PubMed. Transient cardiac effects in a child with acute cholinergic syndrome due to rivastigmine poisoning
Another underrecognized scenario is the patient already on a cholinesterase inhibitor who then encounters a mild organophosphate exposure that would be harmless on its own. Their baseline enzyme activity is already suppressed by the medication, leaving less reserve. Even a small additional insult can push them into symptomatic territory. Clinicians evaluating elderly patients with unexplained “SLUDGE” symptoms should always ask about both prescription medications and possible environmental exposures.
Benzodiazepine-Refractory Seizures
While midazolam is the go-to drug for organophosphate-induced seizures, there is growing recognition that some cases do not respond well. In animal models designed to mimic severe nerve agent poisoning, midazolam’s anticonvulsant effect was limited, and seizure activity continued despite treatment. One study noted that while the drug’s ability to stop seizures was similar in male and female animals, females showed substantially more protection against the brain-cell damage that seizures cause, even when the seizures themselves were not fully controlled.27PubMed Central. Sex Differences in Organophosphate Model of Benzodiazepine-Refractory Status Epilepticus and Neuronal Damage This finding has implications for developing next-generation anticonvulsant therapies and underscores that the longer seizures continue unchecked, the harder they become to stop, regardless of the drug used. Research into alternatives that target different receptors is active, but for now, early and aggressive benzodiazepine use remains the best available strategy.